Epigenetic mechanisms are crucial for regulating gene expression in development and cell differentiation. Dysregulation of epigenetic information is implicated in many human diseases including cancer. We are interested in understanding how multiple levels of epigenetic mechanisms are regulated in normal development and disease states. By focusing on H1 linker histones and epidrugs, we investigate the role of chromatin compaction and chromatin remodeling in development, stem cell biology, and tumorigenesis. We have established H1 and its multiple variants as important epigenetic factors regulating gene expression for development, stem cell differentiation and tumor suppression. We spearheaded genome-wide mapping of H1 variants in embryonic stem cells and classified H1s as causal repressive marks for silencing satellite repetitive sequences and for regulating chromocenter clustering as well as specific DNA methylation and histone modification patterns. Using molecular, cellular, genetic and bioinformatics approaches combined with stem cell technologies, we seek to elucidate how epigenetic regulation interplays with signaling pathways in cell fate determination and ultimately to discover novel therapeutic strategies and targets for regenerative medicine and cancer treatment.
